Saturday, Apr 17, 2021
Focus on the big picture

AstraZeneca Lowers Vaccine Efficacy

Bloomberg, 25 Mar 2021
Mar.25 -- AstraZeneca Plc. has lowered its vaccine efficacy to 76%. The move comes after the results of a U.S. clinical trial were criticized as outdated.
Related Articles